相似文献
1
Activities of flucytosine, fluconazole, amphotericin B, and micafungin in a murine model of disseminated infection by Candida glabrata.
Antimicrob Agents Chemother. 2005 Nov;49(11):4757-9. doi: 10.1128/AAC.49.11.4757-4759.2005.
2
Combined antifungal therapy in a murine infection by Candida glabrata.
J Antimicrob Chemother. 2006 Dec;58(6):1295-8. doi: 10.1093/jac/dkl395. Epub 2006 Sep 29.
3
Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
Antimicrob Agents Chemother. 2005 Dec;49(12):4895-902. doi: 10.1128/AAC.49.12.4895-4902.2005.
4
Efficacy of micafungin against deep-seated candidiasis in cyclophosphamide-induced immunosuppressed mice.
J Antimicrob Chemother. 2005 Apr;55(4):587-90. doi: 10.1093/jac/dki024. Epub 2005 Feb 22.
5
The comparative efficacy of cilofungin, fluconazole and amphotericin B in disseminated Candida tropicalis infection in neutropenic mice.
Clin Invest Med. 1992 Oct;15(5):434-9.
6
Anidulafungin pharmacokinetics and microbial response in neutropenic mice with disseminated candidiasis.
Antimicrob Agents Chemother. 2006 Nov;50(11):3695-700. doi: 10.1128/AAC.00507-06. Epub 2006 Sep 5.
7
Antifungal susceptibility testing of micafungin against Candida glabrata isolates.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Apr;105(4):457-9. doi: 10.1016/j.tripleo.2007.12.003.
8
Caspofungin in combination with amphotericin B against Candida glabrata.
Antimicrob Agents Chemother. 2005 Jun;49(6):2546-9. doi: 10.1128/AAC.49.6.2546-2549.2005.
9
Micafungin combined with fluconazole, an effective therapy for murine blastoschizomycosis.
J Antimicrob Chemother. 2008 Apr;61(4):877-9. doi: 10.1093/jac/dkn012. Epub 2008 Feb 13.
引用本文的文献
1
Role and Interpretation of Antifungal Susceptibility Testing for the Management of Invasive Fungal Infections.
J Fungi (Basel). 2020 Dec 30;7(1):17. doi: 10.3390/jof7010017.
2
In Vitro Susceptibility Testing in Fungi: What is its Role in Clinical Practice?
Curr Infect Dis Rep. 2010 Nov;12(6):401-8. doi: 10.1007/s11908-010-0134-z.
3
Paradoxical growth of Candida dubliniensis does not preclude in vivo response to echinocandin therapy.
Antimicrob Agents Chemother. 2009 Dec;53(12):5297-9. doi: 10.1128/AAC.00980-09. Epub 2009 Sep 28.
4
Efficacy of triazoles in a murine disseminated infection by Candida krusei.
Antimicrob Agents Chemother. 2009 Aug;53(8):3585-8. doi: 10.1128/AAC.00293-09. Epub 2009 May 26.
5
Gain of function mutations in CgPDR1 of Candida glabrata not only mediate antifungal resistance but also enhance virulence.
PLoS Pathog. 2009 Jan;5(1):e1000268. doi: 10.1371/journal.ppat.1000268. Epub 2009 Jan 16.
本文引用的文献
1
In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003.
J Antimicrob Chemother. 2005 Feb;55(2):194-9. doi: 10.1093/jac/dkh548. Epub 2004 Dec 23.
2
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida.
Clin Microbiol Infect. 2004 Mar;10 Suppl 1:11-23. doi: 10.1111/j.1470-9465.2004.t01-1-00844.x.
3
Guidelines for treatment of candidiasis.
Clin Infect Dis. 2004 Jan 15;38(2):161-89. doi: 10.1086/380796. Epub 2003 Dec 19.
4
Efficacy of micafungin alone or in combination against systemic murine aspergillosis.
Antimicrob Agents Chemother. 2003 Apr;47(4):1452-5. doi: 10.1128/AAC.47.4.1452-1455.2003.
5
Efficacy of liposomal amphotericin B in treatment of systemic murine fusariosis.
Antimicrob Agents Chemother. 2002 Jul;46(7):2273-5. doi: 10.1128/AAC.46.7.2273-2275.2002.
6
Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/- knockout mice.
Antimicrob Agents Chemother. 2002 May;46(5):1240-5. doi: 10.1128/AAC.46.5.1240-1245.2002.
7
Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study.
J Clin Microbiol. 2002 Apr;40(4):1298-302. doi: 10.1128/JCM.40.4.1298-1302.2002.
8
Liposomal amphotericin B and granulocyte colony-stimulating factor therapy in a murine model of invasive infection by Scedosporium prolificans.
J Antimicrob Chemother. 2002 Mar;49(3):525-9. doi: 10.1093/jac/49.3.525.
9
Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC).
Clin Infect Dis. 1999 May;28(5):1071-9. doi: 10.1086/514731.
10
Comparison of fluconazole, amphotericin B and flucytosine in treatment of a murine model of disseminated infection with Candida glabrata in immunocompromised mice.
J Antimicrob Chemother. 1995 May;35(5):631-40. doi: 10.1093/jac/35.5.631.
Zotero 插件